Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens

<p dir="ltr">This study evaluated the potential for antibody‐dependent enhancement (ADE) in serum samples from patients exposed to Middle East respiratory syndrome coronavirus (MERS‐CoV). Furthermore, we evaluated the effect of severe acute respiratory syndrome coronavirus 2 (SARS‐Co...

Full description

Saved in:

Bibliographic Details
Main Author:	Swapna Thomas (17337925) (author)
Other Authors:	Maria K. Smatti (4675852) (author), Haya Alsulaiti (22045127) (author), Hadeel T. Zedan (12535521) (author), Ali H. Eid (5461829) (author), Ali A. Hssain (12535536) (author), Laith J. Abu Raddad (16931811) (author), Giusy Gentilcore (15112577) (author), Allal Ouhtit (526) (author), Asmaa A. Althani (4675855) (author), Gheyath K. Nasrallah (9200525) (author), Jean‐Charles Grivel (22045130) (author), Hadi M. Yassine (4675846) (author)
Published:	2024
Subjects:	Biomedical and clinical sciences Clinical sciences Immunology Health sciences Public health COVID-19 Vaccination Pseudovirus Assay Neutralizing Antibodies Cross-Reactive Immunity Viral Pathogenesis Post-Infection Immunity
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens

Similar Items